Aspirin resistance: definition, mechanisms and clinical read-outs

[1] *AM TRIAL COLL, 2002, BMJ-BRIT MED J, V324, P71

[2] Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease [J]. THROMBOSIS RESEARCH, 2002, 108 (01) : 37 - 42

[3] Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease - A reappraisal [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 12 - 20

[4] PERSISTENT INHIBITION OF PLATELET-FUNCTION DURING LONG-TERM TREATMENT WITH 75 MG ACETYLSALICYLIC-ACID DAILY IN MEN WITH UNSTABLE CORONARY-ARTERY DISEASE [J]. EUROPEAN HEART JOURNAL, 1991, 12 (03) : 428 - 433

[5] FAILURE OF ASPIRIN TREATMENT AFTER STROKE [J]. STROKE, 1994, 25 (02) : 275 - 277

[6] BUCHANAN MR, 1995, CAN J CARDIOL, V11, P221

[7] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817

[8] Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (02) : 110 - 114

[9] Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina [J]. CIRCULATION, 2000, 102 (09) : 1007 - 1013

[10] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J]. CIRCULATION, 2002, 105 (14) : 1650 - 1655

[1] *AM TRIAL COLL, 2002, BMJ-BRIT MED J, V324, P71

[2] Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease [J]. THROMBOSIS RESEARCH, 2002, 108 (01) : 37 - 42

[3] Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease - A reappraisal [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 12 - 20

[4] PERSISTENT INHIBITION OF PLATELET-FUNCTION DURING LONG-TERM TREATMENT WITH 75 MG ACETYLSALICYLIC-ACID DAILY IN MEN WITH UNSTABLE CORONARY-ARTERY DISEASE [J]. EUROPEAN HEART JOURNAL, 1991, 12 (03) : 428 - 433

[5] FAILURE OF ASPIRIN TREATMENT AFTER STROKE [J]. STROKE, 1994, 25 (02) : 275 - 277

[6] BUCHANAN MR, 1995, CAN J CARDIOL, V11, P221

[7] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817

[8] Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (02) : 110 - 114

[9] Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina [J]. CIRCULATION, 2000, 102 (09) : 1007 - 1013

[10] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J]. CIRCULATION, 2002, 105 (14) : 1650 - 1655